Feb. 19, 2019, 3:15 PM CST
By Shamard Charles, M.D.
https://www.nbcnews.com/health/aging/young-blood-company-ambrosia-halts-patient-treatments-after-fda-warning-n973266
Other medical establishments, such as the Maharaj Institute in Florida, have started expensive clinical trials and openly discussed plans to charge patients for transfusions of plasma from young donors.In fact, people considering enrolling said they had been told they would have to pay $285,000, STAT reported last March.